BioSpace News Archive

Business

GlycoMimetics Announces NCI-Sponsored Pivotal Trial of GMI-1271 in Older, Newly Diagnosed AML Patients Fit for Intensive Chemotherapy

Third of three planned trials positions GlycoMimetics to address unmet needs across the AML spectrum

May 30, 2018

·

4 min read

FDA

Legend Announces FDA clearance of IND application on CAR-T immuno-cell therapy for the Treatment of Multiple Myeloma

LCAR-B38M CAR-T therapy (JNJ-68284528) to be developed as part of strategic partnership between Legend and Janssen

May 30, 2018

·

4 min read

Policy

Artelo Biosciences Commences Trading On OTCQB

Artelo Biosciences, Inc. is pleased to announce that as of May 21, 2018, its shares began trading on the OTCQB under the symbol ARTL.

May 30, 2018

·

3 min read

Biotech Bay

Eiger BioPharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference

Eiger BioPharmaceuticals, Inc. announced that David Cory, President and CEO, will present a corporate update at Jefferies 2018 Global Healthcare Conference.

May 30, 2018

·

1 min read

Policy

BIOLASE Regains Compliance With Nasdaq Minimum Bid Price Requirement

BIOLASE, Inc. announced that it has received a letter from Nasdaq Listing Qualifications confirming that the Company has regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq Capital Market.

May 30, 2018

·

4 min read

Drug Development

Janssen Announces Initiation of Phase 1b/2 Clinical Development Program Evaluating JNJ-68284528 CAR-T Cells for the Treatment of Multiple Myeloma

Planned Start of Clinical Program and Clearance of U.S. Food and Drug Administration Investigational New Drug Application Reflect Progress in Strategic Partnership with Legend Biotech

May 30, 2018

·

6 min read

Business

Walgreens Boots Alliance Schedules Fiscal 2018 Third Quarter Earnings Announcement for 28 June 2018

Walgreens Boots Alliance, Inc. will release its fiscal 2018 third quarter earnings results at 7 a.m. Eastern time Thursday, 28 June 2018.

May 30, 2018

·

3 min read

Biotech Bay

Ancora Heart Announces $17.8 Million Financing for First-of-Its-Kind Therapy for Systolic Heart Failure

– Funds Will Support Continued Clinical Evaluation of the AccuCinch Left Ventricular Repair System –

May 30, 2018

·

3 min read

Biotech Bay

Varian Halcyon Systems Expand Access to Cancer Care at Three Centers in Africa

Treatments with Varian’s Halcyon™ system have started at three different cancer centers in northern and southern Africa.

May 30, 2018

·

3 min read

Policy

Oramed Patent Titled “Methods and Compositions for Oral Administrations of Proteins,” Allowed in the US for Oral Administration of Proteins

Oramed Pharmaceuticals Inc. announced that the Company’s patent for its invention, titled “Methods and Compositions for Oral Administrations of Proteins,” has been allowed by the United States Patent and Trademark Office.

May 30, 2018

·

3 min read